Mitochondrial Agents for Bipolar Disorder – International Journal of Neuropsychopharmacology – 27 March 2018

Abstract - Background: "Bipolar disorder is a chronic and often debilitating illness. Current treatment options (both pharmaco- and psychotherapy) have shown efficacy, but for many leave a shortfall in recovery. Advances in the understanding of the pathophysiology of bipolar disorder suggest that interventions that target mitochondrial dysfunction may provide a therapeutic benefit."
Facebook
Google+
Twitter
LinkedIn
Pinterest